Zisuva 375/Zisuva 625/Zisuva 1G/Zisuva DS/Zisuva 600/Zisuva 1200 Indications/Uses

Zisuva 375/Zisuva 625/Zisuva 1G/Zisuva DS: Treatment of otitis media, sinusitis, and infections caused by susceptible organisms involving the lower respiratory tract, skin and skin structure, and urinary tract: spectrum same as amoxicillin with additional coverage of beta-lactamase producing B. catarrhalis, H. influenzae, N. gonorrhoeae, and S. aureus (not MRSA). The expanded coverage of this combination makes it a useful alternative when amoxicillin resistance is present and patients cannot tolerate alternative treatments.
Zisuva 600/Zisuva 1200: ZISUVA injection is indicated for the treatment of the following infections in adults and children: Severe infections of the ear, nose and throat (such as mastoiditis, peritonsillar infections, epiglottitis, and sinusitis when accompanied by severe systemic signs and symptoms), Acute exacerbations of chronic bronchitis (adequately diagnosed), Community acquired pneumonia, Cystitis, Pyelonephritis, Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis, Bone and joint infections, in particular osteomyelitis, Intra-abdominal infections, Female genital infections.
Prophylaxis against infections associated with major surgical procedures in adults, such as those involving the Gastrointestinal tract, Pelvic cavity, Head and neck, Biliary tract surgery.